Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Per Venge

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Cardiopulmonary Bypass

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
40
Lindahl, Bertil
35
Wallentin, Lars
18
Håkansson, Lena
16
Hällgren, Roger
14
Stålenheim, Gunnemar
13
Håkansson, Lena
13
Amin, Kawa
13
Janson, Christer
12
Jernberg, Tomas
12
Norbäck, Dan
12
Sevéus, Lahja
12
Siegbahn, Agneta
11
Wieslander, Gunilla
11
Lagerqvist, Bo
10
Borowiec, Jan

Sign-in to see all Coauthors

Publications

TOP 3
Lind Lars; Wallentin Lars; Kempf Tibor; Tapken Heike; Quint Anja; Lindahl Bertil; Olofsson Sylvia; Venge Per; Larsson Anders; Hulthe Johannes; Elmgren Anders; Wollert Kai C
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.
Venge Per; Johnston Nina; Lindahl Bertil; James Stefan
Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
Woschnagg Charlotte; Rubin Jenny; Venge Per
Eosinophil cationic protein (ECP) is processed during secretion.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Per Venge (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lind Lars; Wallentin Lars; Kempf Tibor; Tapken Heike; Quint Anja; Lindahl Bertil; Olofsson Sylvia; Venge Per; Larsson Anders; Hulthe Johannes; Elmgren Anders; Wollert Kai C
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.
European heart journal 2009;30(19):2346-53.
2009: Venge Per; Johnston Nina; Lindahl Bertil; James Stefan
Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
Journal of the American College of Cardiology 2009;54(13):1165-72.
2009: Woschnagg Charlotte; Rubin Jenny; Venge Per
Eosinophil cationic protein (ECP) is processed during secretion.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(6):3949-54.
2009: Smerud Hilde Kloster; Fellström Bengt; Hällgren Roger; Osagie Sonia; Venge Per; Kristjánsson Gudjón
Gluten sensitivity in patients with IgA nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(8):2476-81.
2009: Eggers Kai M; Lagerqvist Bo; Venge Per; Wallentin Lars; Lindahl Bertil
Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Journal of the American College of Cardiology 2009;54(4):357-64.
2009: Rubin Jenny; Zagai Ulrika; Blom Kristin; Trulson Agneta; Engström Ake; Venge Per
The coding ECP 434(G>C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(1):445-51.
2009: Woschnagg Charlotte; Forsberg Jens; Engström Ake; Odreman Federico; Venge Per; Garcia Rodolfo C
The human eosinophil proteome. Changes induced by birch pollen allergy.
Journal of proteome research 2009;8(6):2720-32.
2009: Cai Linjun; Borowiec Jan; Xu Shengyuan; Han Wenyu; Venge Per
Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances.
Clinica chimica acta; international journal of clinical chemistry 2009;403(1-2):121-5.
2009: Eggers Kai M; Lindahl Bertil; Venge Per; Lind Lars
B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years.
The American journal of cardiology 2009;103(7):1032-8.
2009: Zagai U; Lundahl J; Klominek J; Venge P; Sköld C M
Eosinophil cationic protein stimulates migration of human lung fibroblasts in vitro.
Scandinavian journal of immunology 2009;69(4):381-6.
2009: Sundström Johan; Ingelsson Erik; Berglund Lars; Zethelius Björn; Lind Lars; Venge Per; Arnlöv Johan
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
European heart journal 2009;30(7):773-81.
2009: Eggers Kai M; Lind Lars; Venge Per; Lindahl Bertil
Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction?
The American journal of cardiology 2009;103(5):588-91.
2009: Venge Per; Arnlöv Johan; Zethelius Björn
Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study.
Scandinavian journal of clinical and laboratory investigation 2009;69(3):418-24.
2008: Eggers Kai M; Lagerqvist Bo; Oldgren Jonas; Venge Per; Wallentin Lars; Lindahl Bertil
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.
American heart journal 2008;156(3):588-94.
2008: Eggers Kai M; Lind Lars; Ahlström Håkan; Bjerner Tomas; Ebeling Barbier Charlotte; Larsson Anders; Venge Per; Lindahl Bertil
Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects.
European heart journal 2008;29(18):2252-8.
2008: Eggers Kai M; Dellborg Mikael; Oldgren Jonas; Swahn Eva; Venge Per; Lindahl Bertil
Risk prediction in chest pain patients by biochemical markers including estimates of renal function.
International journal of cardiology 2008;128(2):207-13.
2008: Lidén M; Kristjánsson G; Valtysdottir S; Venge P; Hällgren R
Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren's syndrome.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2008;38(6):929-35.
2008: Zethelius Björn; Berglund Lars; Sundström Johan; Ingelsson Erik; Basu Samar; Larsson Anders; Venge Per; Arnlöv Johan
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
The New England journal of medicine 2008;358(20):2107-16.
2008: Pauksens Karlis; Fjaertoft Gustav; Douhan-Håkansson Lena; Venge Per
Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia.
Scandinavian journal of infectious diseases 2008;40(4):326-37.
2007: Eriksson Jenny; Woschnagg Charlotte; Fernvik Eva; Venge Per
A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein.
Journal of leukocyte biology 2007;82(6):1491-500.
2007: Eggers Kai M; Lagerqvist Bo; Venge Per; Wallentin Lars; Lindahl Bertil
Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
Circulation 2007;116(17):1907-14.
2007: Wollert Kai C; Kempf Tibor; Lagerqvist Bo; Lindahl Bertil; Olofsson Sylvia; Allhoff Tim; Peter Timo; Siegbahn Agneta; Venge Per; Drexler Helmut; Wallentin Lars
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
Circulation 2007;116(14):1540-8.
2007: Cooray Ruby; Waller Karin Persson; Venge Per
Haptoglobin comprises about 10% of granule protein extracted from bovine granulocytes isolated from healthy cattle.
Veterinary immunology and immunopathology 2007;119(3-4):310-5.
2007: Zagai Ulrika; Dadfar Elham; Lundahl Joachim; Venge Per; Sköld C Magnus
Eosinophil cationic protein stimulates TGF-beta1 release by human lung fibroblasts in vitro.
Inflammation 2007;30(5):153-60.
2007: Eriksson Jenny; Reimert Claus M; Kabatereine Narcis B; Kazibwe Francis; Ireri Edmund; Kadzo Hilda; Eltahir Hanan B; Mohamed Abdelrahim O; Vennervald Birgitte J; Venge Per
The 434(G>C) polymorphism within the coding sequence of Eosinophil Cationic Protein (ECP) correlates with the natural course of Schistosoma mansoni infection.
International journal for parasitology 2007;37(12):1359-66.
2007: Tang Li-Jun; De Seta Francesco; Odreman Federico; Venge Per; Piva Caterina; Guaschino Secondo; Garcia Rodolfo C
Proteomic analysis of human cervical-vaginal fluids.
Journal of proteome research 2007;6(7):2874-83.
2007: Kristjánsson G; Venge P; Hällgren R
Mucosal reactivity to cow's milk protein in coeliac disease.
Clinical and experimental immunology 2007;147(3):449-55.
2007: Wieslander G; Norbäck D; Venge P
Changes of symptoms, tear film stability and eosinophilic cationic protein in nasal lavage fluid after re-exposure to a damp office building with a history of flooding.
Indoor air 2007;17(1):19-27.
2007: Trulson A; Byström J; Engström A; Larsson R; Venge P
The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2007;37(2):208-18.
2007: Rundström Gerd; Jonsson Ann; Mårtensson Ola; Mendel-Hartvig Ib; Venge Per
Lateral flow immunoassay using Europium (III) chelate microparticles and time-resolved fluorescence for eosinophils and neutrophils in whole blood.
Clinical chemistry 2007;53(2):342-8.
2007: Fjaertoft Gustav; Håkansson Lena Douhan; Pauksens Karlis; Sisask Gregor; Venge Per
Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery.
Scandinavian journal of infectious diseases 2007;39(6-7):525-35.
2006: ElShafie Amir Ibrahim; Elghazali Gehad; Rönnelid Johan; Venge Per
Cystatin C as a marker of immune complex-associated renal impairment in a Sudanese population with visceral leishmaniasis.
The American journal of tropical medicine and hygiene 2006;75(5):864-8.
2006: Lampinen Maria; Oberg Gunnar; Venge Per; Carlson Marie
Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2006;114(11):757-63.
2006: James Stefan K; Lindbäck Johan; Tilly Johanna; Siegbahn Agneta; Venge Per; Armstrong Paul; Califf Robert; Simoons Maarten L; Wallentin Lars; Lindahl Bertil
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2006;48(6):1146-54.
2006: Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
Heart (British Cardiac Society) 2006;92(6):735-40.
2006: James Stefan; Flodin Mats; Johnston Nina; Lindahl Bertil; Venge Per
The antibody configurations of cardiac troponin I assays may determine their clinical performance.
Clinical chemistry 2006;52(5):832-7.
2006: Jernberg Tomas; Boman Kurt; James Stefan; Lindahl Bertil; Stridsberg Mats; Swedberg Karl; Venge Per
[BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation]
Läkartidningen 2006;103(17):1289-92, 1295.
2006: Jönsson Ulla-Britt; Byström Jonas; Stålenheim Gunnemar; Venge Per
A (G->C) transversion in the 3' UTR of the human ECP (eosinophil cationic protein) gene correlates to the cellular content of ECP.
Journal of leukocyte biology 2006;79(4):846-51.
2006: Furebring M; Håkansson L; Venge P; Sjölin J
C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes.
Scandinavian journal of immunology 2006;63(3):208-16.
2006: Zethelius Björn; Johnston Nina; Venge Per
Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.
Circulation 2006;113(8):1071-8.
2006: Lampinen Maria; Håkansson Lena Douhan; Venge Per
Albumin stimulation of eosinophil migration involves PI3-kinases and is associated with diminished eosinophil CD49d and CD49f expression.
International archives of allergy and immunology 2006;140(2):113-20.
2005: Amin Kawa; Janson Christer; Harvima Ilkka; Venge Per; Nilsson Gunnar
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma.
The Journal of allergy and clinical immunology 2005;116(6):1383-6.
2005: Wålinder Robert; Ernstgård Lena; Johanson Gunnar; Norbäck Dan; Venge Per; Wieslander Gunilla
Acute effects of a fungal volatile compound.
Environmental health perspectives 2005;113(12):1775-8.
2005: Amin K; Janson C; Boman G; Venge P
The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma.
Allergy 2005;60(10):1241-7.
2005: Lagerqvist B; Diderholm E; Lindahl B; Husted S; Kontny F; Ståhle E; Swahn E; Venge P; Siegbahn A; Wallentin L
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease.
Heart (British Cardiac Society) 2005;91(8):1047-52.
2005: Fjaertoft Gustav; Foucard Tony; Xu Shengyuan; Venge Per
Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics.
Acta paediatrica (Oslo, Norway : 1992) 2005;94(6):661-6.
2005: Kristjansson Gudjon; Serra Jordi; Lööf Lars; Venge Per; Hällgren Roger
Kinetics of mucosal granulocyte activation after gluten challenge in coeliac disease.
Scandinavian journal of gastroenterology 2005;40(6):662-9.
2005: Vahlquist Anders; Westermark Per; Ståhle Elisabeth; Venge Per; Påhlman Lars; Hällgren Roger; Rönnblom Lars; Kämpe Olle; Wiklund Lars; Aquilonius Sten-Magnus; Alm Albert
[Burdensome rules for clinical trials are not in proportion to benefits for the patient]
Läkartidningen 2005;102(23):1832, 1834; discussion 1834.
2005: Jernberg Tomas; James Stefan; Lindahl Bertil; Stridsberg Mats; Venge Per; Wallentin Lars
NT-ProBNP in non-ST-elevation acute coronary syndrome.
Journal of cardiac failure 2005;11(5 Suppl):S54-8.
2005: Kristjánsson G; Högman M; Venge P; Hällgren R
Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn.
Gut 2005;54(6):769-74.
2005: Xu Shengyuan; Zhao Linshu; Larsson Anders; Smeds Emanuel; Kusche-Gullberg Marion; Venge Per
Purification of a 75 kDa protein from the organelle matrix of human neutrophils and identification as N-acetylglucosamine-6-sulphatase.
The Biochemical journal 2005;387(Pt 3):841-7.
2005: Shahana S; Björnsson E; Lúdvíksdóttir D; Janson C; Nettelbladt O; Venge P; Roomans G M;
Ultrastructure of bronchial biopsies from patients with allergic and non-allergic asthma.
Respiratory medicine 2005;99(4):429-43.
2005: Fjaertoft G; Håkansson L; Foucard T; Ewald U; Venge P
CD64 (Fcgamma receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants.
Acta paediatrica (Oslo, Norway : 1992) 2005;94(3):295-302.
2005: Lindahl Bertil; Lindbäck Johan; Jernberg Tomas; Johnston Nina; Stridsberg Mats; Venge Per; Wallentin Lars
Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
Journal of the American College of Cardiology 2005;45(4):533-41.
2005: Ekberg-Jansson A; Amin K; Bake B; Rosengren A; Tylén U; Venge P; Löfdahl C G
Bronchial mucosal mast cells in asymptomatic smokers relation to structure, lung function and emphysema.
Respiratory medicine 2005;99(1):75-83.
2005: Janson Christer; Ludviksdottir Dora; Gunnbjörnsdottir María; Björnsson Eythor H; Håkansson Lena; Venge Per;
Circulating adhesion molecules in allergic and non-allergic asthma.
Respiratory medicine 2005;99(1):45-51.
2005: Fjaertoft Gustav; Pauksen Karlis; Håkansson Lena; Xu Shengyuan; Venge Per
Cell surface expression of FcgammaRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications.
Scandinavian journal of infectious diseases 2005;37(11-12):882-9.
2005: Amin Kawa; Janson Christer; Sevéus Lahja; Miyazaki Kaoru; Virtanen Ismo; Venge Per
Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics.
Respiratory research 2005;6():110.
2005: Ivanov Stefan; Palmberg Lena; Venge Per; Larsson Kjell; Lindén Anders
Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust.
Respiratory research 2005;6():44.
2004: Kristjánsson G; Venge P; Wanders A; Lööf L; Hällgren R
Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.
Gut 2004;53(12):1806-12.
2004: Furebring M; Håkansson L; Venge P; Sjölin J
Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes.
Scandinavian journal of immunology 2004;60(5):494-9.
2004: Woschnagg C; Venge P; Garcia R C
The effect of IL-5 treatment on the stimulation-induced phosphorylation of proteins in blood eosinophils.
Cytokine 2004;28(3):137-48.
2004: Zhao Linshu; Xu Shengyuan; Fjaertoft Gustav; Pauksen Karlis; Håkansson Lena; Venge Per
An enzyme-linked immunosorbent assay for human carcinoembryonic antigen-related cell adhesion molecule 8, a biological marker of granulocyte activities in vivo.
Journal of immunological methods 2004;293(1-2):207-14.
2004: Jernberg Tomas; James Stefan; Lindahl Bertil; Johnston Nina; Stridsberg Mats; Venge Per; Wallentin Lars
Natriuretic peptides in unstable coronary artery disease.
European heart journal 2004;25(17):1486-93.
2004: Lampinen M; Carlson M; Håkansson L D; Venge P
Cytokine-regulated accumulation of eosinophils in inflammatory disease.
Allergy 2004;59(8):793-805.
2004: Zhao Linshu; Furebring Mia; Xu Shengyuan; Venge Per
Subcellular localization and mobilization of carcinoembryonic antigen-related cell adhesion molecule 8 in human neutrophils.
British journal of haematology 2004;125(5):666-73.
2004: James Stefan; Lindahl Bertil; Siegbahn Agneta; Stridsberg Mats; Venge Per; Wallentin Lars
[Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice]
Läkartidningen 2004;101(17):1514-9, 1521-2.
2004: Zagai U; Sköld C M; Trulson A; Venge P; Lundahl J
The effect of eosinophils on collagen gel contraction and implications for tissue remodelling.
Clinical and experimental immunology 2004;135(3):427-33.
2004: Hohlfeld Jens M; Schmiedl Andreas; Erpenbeck Veit J; Venge Per; Krug Norbert
Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma.
The Journal of allergy and clinical immunology 2004;113(3):496-502.
2004: Jernberg Tomas; James Stefan; Lindahl Bertil; Stridsberg Mats; Venge Per; Wallentin Lars
NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(3):319-25.
2004: Johnston Nina; Jernberg Tomas; Lindahl Bertil; Lindbäck Johan; Stridsberg Mats; Larsson Anders; Venge Per; Wallentin Lars
Biochemical indicators of cardiac and renal function in a healthy elderly population.
Clinical biochemistry 2004;37(3):210-6.
2004: James Stefan K; Lindahl Bertil; Armstrong Paul; Califf Robert; Simoons M L Maarten L; Venge Per; Wallentin Lars;
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.
International journal of cardiology 2004;93(2-3):113-20.
2004: Björklund Erik; Lindahl Bertil; Johanson Per; Jernberg Tomas; Svensson Ann Marie; Venge Per; Wallentin Lars; Dellborg Mikael;
Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction.
European heart journal 2004;25(2):113-20.
2004: Venge P
Monitoring the allergic inflammation.
Allergy 2004;59(1):26-32.
2003: Jernberg Tomas; Lindahl Bertil; Siegbahn Agneta; Andren Bertil; Frostfeldt Gunnar; Lagerqvist Bo; Stridsberg Mats; Venge Per; Wallentin Lars
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
Journal of the American College of Cardiology 2003;42(11):1909-16.
2003: Venge Per; Moberg Lena; Björnsson Eythor; Bergström Mats; Långström Bengt; Håkansson Lena
Mechanisms of basal and cytokine-induced uptake of glucose in normal human eosinophils: relation to apoptosis.
Respiratory medicine 2003;97(10):1109-19.
2003: Seton K; Håkansson L; Venge P
Enhanced adhesion to laminin by apoptotic eosinophils.
Scandinavian journal of immunology 2003;58(4):412-8.
2003: Seton K; Håkansson L; Karawajczyk M; Venge P
The stimulus-dependent release of eosinophil cationic protein and eosinophil protein x increases in apoptotic eosinophils.
Scandinavian journal of immunology 2003;58(3):312-20.
2003: James Stefan; Armstrong Paul; Califf Robert; Simoons Maarten L; Venge Per; Wallentin Lars; Lindahl Bertil
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.
The American journal of medicine 2003;115(3):178-84.
2003: Seton Kristina; Håkansson Lena; Carlson Marie; Stålenheim Gunnemar; Venge Per
Apoptotic eosinophils express IL-2R chains alpha and beta and co-stimulatory molecules CD28 and CD86.
Respiratory medicine 2003;97(8):893-902.
2003: James Stefan K; Lindahl Bertil; Siegbahn Agneta; Stridsberg Mats; Venge Per; Armstrong Paul; Barnathan Elliot S; Califf Robert; Topol Eric J; Simoons Maarten L; Wallentin Lars
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
Circulation 2003;108(3):275-81.
2003: Mohammed Abdelrahim O; Elghazali Gehad; Mohammed Hassabo B; Elbashir Mustafa I; Xu Shengyuan; Berzins Klavs; Venge Per
Human neutrophil lipocalin: a specific marker for neutrophil activation in severe Plasmodium falciparum malaria.
Acta tropica 2003;87(2):279-85.
2003: Venge Per; Johnston Nina; Lagerqvist Bo; Wallentin Lars; Lindahl Bertil;
Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.
Clinical chemistry 2003;49(6 Pt 1):880-6.
2003: Liu Lixin; Hakansson Lena; Ridefelt Peter; Garcia Rodolfo C; Venge Per
Priming of eosinophil migration across lung epithelial cell monolayers and upregulation of CD11b/CD18 are elicited by extracellular Ca2+.
American journal of respiratory cell and molecular biology 2003;28(6):713-21.
2003: James Stefan K; Armstrong Paul; Barnathan Elliott; Califf Robert; Lindahl Bertil; Siegbahn Agneta; Simoons Maarten L; Topol Eric J; Venge Per; Wallentin Lars;
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2003;41(6):916-24.
2003: Holmvang Lene; Clemmensen Peter; Lindahl Bertil; Lagerqvist Bo; Venge Per; Wagner Galen; Wallentin Lars; Grande Peer
Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment.
Journal of the American College of Cardiology 2003;41(6):905-15.
2003: Amin K; Ekberg-Jansson A; Löfdahl C-G; Venge P
Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.
Thorax 2003;58(2):135-42.
2003: Jernberg Tomas; Venge Per; Lindahl Bertil
Comparison between second and third generation troponin T assay in patients with symptoms suggestive of an acute coronary syndrome but without ST segment elevation.
Cardiology 2003;100(1):29-35.
2003: Lannergård Anders; Hersio Kristina; Larsson Anders; Pauksen Karlis; Venge Per; Ståhle Elisabeth; Friman Göran
Evaluation of laboratory markers for the detection of infections in open-heart surgery patients.
Scandinavian journal of infectious diseases 2003;35(2):121-6.
2002: Zhao Linshu; Xu Shengyuan; Peterson Christer; Kuroki Motomu; Kuroki Masahide; Venge Per
Purification and characterization of a 95-kDa protein--carcinoembryonic antigen-related cell adhesion molecule 8--from normal human granulocytes.
Journal of immunological methods 2002;270(1):27-35.
2002: Aldridge Ruth E; Chan Tim; van Dalen Christine J; Senthilmohan Revathy; Winn Marti; Venge Per; Town G Ian; Kettle Anthony J
Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics.
Free radical biology & medicine 2002;33(6):847-56.
2002: Furebring Mia; Håkansson Lena Douhan; Venge Per; Nilsson Bo; Sjölin Jan
Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis.
Critical care (London, England) 2002;6(4):363-70.
2002: Jernberg Tomas; Stridsberg Mats; Venge Per; Lindahl Bertil
N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.
Journal of the American College of Cardiology 2002;40(3):437-45.
2002: Jönsson U-B; Byström J; Stålenheim G; Venge P
Polymorphism of the eosinophil cationic protein-gene is related to the expression of allergic symptoms.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(7):1092-5.
2002: Byström J; Garcia R C; Håkansson L; Karawajczyk M; Moberg L; Soukka J; Venge P
Eosinophil cationic protein is stored in, but not produced by, peripheral blood neutrophils.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(7):1082-91.
2002: Uettwiller-Geiger Denise; Wu Alan H B; Apple Fred S; Jevans Anthony W; Venge Per; Olson Marilyn D; Darte Claude; Woodrum David L; Roberts Sean; Chan Stephen
Multicenter evaluation of an automated assay for troponin I.
Clinical chemistry 2002;48(6 Pt 1):869-76.
2002: Diderholm Erik; Andrén Bertil; Frostfeldt Gunnar; Genberg Margareta; Jernberg Tomas; Lagerqvist Bo; Lindahl Bertil; Venge Per; Wallentin Lars;
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy.
American heart journal 2002;143(5):760-7.
2002: Hurst David S; Venge Per
The impact of atopy on neutrophil activity in middle ear effusion from children and adults with chronic otitis media.
Archives of otolaryngology--head & neck surgery 2002;128(5):561-6.
2002: Venge Per; Lagerqvist B o; Diderholm Erik; Lindahl Bertil; Wallentin Lars
Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).
The American journal of cardiology 2002;89(9):1035-41.
2002: Metso Tuula; Venge P; Haahtela T; Peterson C G B; Sevéus L
Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects.
Thorax 2002;57(5):449-51.
2002: Carlson M; Raab Y; Sevéus L; Xu S; Hällgren R; Venge P
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.
Gut 2002;50(4):501-6.
2001: Rak S; Heinrich C; Jacobsen L; Scheynius A; Venge P
A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.
The Journal of allergy and clinical immunology 2001;108(6):921-8.
2001: Amin K; Lúdvíksdóttir D; Janson C; Nettelbladt O; Gudbjörnsson B; Valtysdóttir S; Björnsson E; Roomans G M; Boman G; Sevéus L; Venge P;
Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome.
Respiratory medicine 2001;95(11):904-10.
2001: Dahlén I; Janson C; Björnsson E; Stålenheim G; Peterson C G; Venge P
Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease.
Respiratory medicine 2001;95(11):891-7.
2001: Lindahl B; Diderholm E; Lagerqvist B; Venge P; Wallentin L;
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy.
Journal of the American College of Cardiology 2001;38(4):979-86.
2001: Lampinen M; Carlson M; Sangfelt P; Taha Y; Thörn M; Lööf L; Raab Y; Venge P
IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis.
Digestive diseases and sciences 2001;46(9):2004-9.
2001: Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
British journal of haematology 2001;114(3):616-23.
2001: Molin D; Glimelius B; Sundström C; Venge P; Enblad G
The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Leukemia & lymphoma 2001;42(3):457-65.
2001: Byström J; Tenno T; Håkansson L; Amin K; Trulson A; Högbom E; Venge P
Monocytes, but not macrophages, produce the eosinophil cationic protein.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2001;109(7-8):507-16.
2001: Moberg L; Karawajczyk M; Venge P
(99m)Tc-HMPAO (Ceretec) is stored in and released from the granules of eosinophil granulocytes.
British journal of haematology 2001;114(1):185-90.
2001: Woschnagg C; Garcia R C; Venge P
The mechanisms of serum-treated zymosan (STZ)-induced oxidative metabolism by human eosinophils and the effects of IL-5 priming.
Allergy 2001;56(7):639-45.
2001: Ekberg-Jansson A; Andersson B; Bake B; Boijsen M; Enanden I; Rosengren A; Skoogh B E; Tylén U; Venge P; Löfdahl C G
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT.
Respiratory medicine 2001;95(5):363-73.
2001: Frostfeldt G; Gustafsson G; Lindahl B; Nygren A; Venge P; Wallentin L
Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarction.
Coronary artery disease 2001;12(3):227-37.
2001: Venge P; Lindahl B; Wallentin L
New generation cardiac troponin I assay for the access immunoassay system.
Clinical chemistry 2001;47(5):959-61.
2001: Woschnagg C; Garcia R; Rak S; Venge P
IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2001;31(4):555-64.
2001: Wålinder R; Norbäck D; Wieslander G; Smedje G; Erwall C; Venge P
Acoustic rhinometry and lavage biomarkers in relation to some building characteristics in Swedish schools.
Indoor air 2001;11(1):2-9.
2001: Lampinen M; Håkansson L; Venge P
Interleukin-2 inhibits eosinophil migration but is counteracted by IL-5 priming.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2001;31(2):249-58.
2001: Amin K; Rinne J; Haahtela T; Simola M; Peterson C G; Roomans G M; Malmberg H; Venge P; Sevéus L
Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration.
The Journal of allergy and clinical immunology 2001;107(2):249-57.
2001: Wålinder R; Norbäck D; Wessen B; Venge P
Nasal lavage biomarkers: effects of water damage and microbial growth in an office building.
Archives of environmental health 2001;56(1):30-6.
2001: Kulander L; Pauksens K; Venge P
Soluble adhesion molecules, cytokines and cellular markers in serum in patients with acute infections.
Scandinavian journal of infectious diseases 2001;33(4):290-300.
2000: Wålinder R; Norbäck D; Wieslander G; Smedje G; Erwall C; Venge P
Acoustic rhinometry in epidemiological studies--nasal reactions in Swedish schools.
Rhinology. Supplement 2000;16():59-64.
2000: Wieslander G; Lindgren T; Norbäck D; Venge P
Changes in the ocular and nasal signs and symptoms of aircrews in relation to the ban on smoking on intercontinental flights.
Scandinavian journal of work, environment & health 2000;26(6):514-22.
2000: Amin K; Lúdvíksdóttir D; Janson C; Nettelbladt O; Björnsson E; Roomans G M; Boman G; Sevéus L; Venge P
Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group.
American journal of respiratory and critical care medicine 2000;162(6):2295-301.
2000: Nupponen I; Venge P; Pohjavuori M; Lassus P; Andersson S
Phagocyte activation in preterm infants following premature rupture of the membranes or chorioamnionitis.
Acta paediatrica (Oslo, Norway : 1992) 2000;89(10):1207-12.
2000: Xu S; Venge P
Lipocalins as biochemical markers of disease.
Biochimica et biophysica acta 2000;1482(1-2):298-307.
2000: Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
The New England journal of medicine 2000;343(16):1139-47.
2000: Karawajczyk M; Sevéus L; Garcia R; Björnsson E; Peterson C G; Roomans G M; Venge P
Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season.
American journal of respiratory cell and molecular biology 2000;23(4):521-9.
2000: Wålinder R; Wieslander G; Norbäck D; Erwall C; Venge P
Influence of personal factors on nasal patency and lavage biomarkers in white-collar workers.
Rhinology 2000;38(3):130-5.
2000: Lahtinen M; Borowiec J; Venge P; Henze P; Stiernström H
Nitric oxide increases leukocyte granule release during simulated extracorporeal circulation.
The Thoracic and cardiovascular surgeon 2000;48(3):151-6.
2000: Sandström K; Håkansson L; Lukinius A; Venge P
A method to study apoptosis in eosinophils by flow cytometry.
Journal of immunological methods 2000;240(1-2):55-68.
2000: Björk A; Venge P; Peterson C G
Measurements of ECP in serum and the impact of plasma coagulation.
Allergy 2000;55(5):442-8.
2000: Hurst D S; Venge P
Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy.
Allergy 2000;55(5):435-41.
2000: Borowiec J W; Lahtinen M; Venge P; Henze A; Stiernström H
Inflammatory response during simulated extracorporeal circulation with addition of nitric oxide.
The Journal of cardiovascular surgery 2000;41(2):207-13.
2000: Xu S; Höglund M; Hâkansson L; Venge P
Granulocyte colony-stimulating factor (G-CSF) induces the production of cytokines in vivo.
British journal of haematology 2000;108(4):848-53.
2000: Lúdvíksdóttir D; Janson C; Björnsson E; Stålenheim G; Boman G; Hedenström H; Venge P; Gudbjörnsson B; Valtysdóttir S
Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness.
Allergy 2000;55(3):259-65.
2000: Olsson C; Siegbahn A; Haldén E; Nilsson B; Venge P; Thelin S
No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits.
The Annals of thoracic surgery 2000;69(3):743-9.
2000: Norbäck D; Wålinder R; Wieslander G; Smedje G; Erwall C; Venge P
Indoor air pollutants in schools: nasal patency and biomarkers in nasal lavage.
Allergy 2000;55(2):163-70.
2000: Olsson C; Siegbahn A; Henze A; Nilsson B; Venge P; Joachimsson P O; Thelin S
Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.
Scandinavian cardiovascular journal : SCJ 2000;34(1):33-40.
1999: Amin K; Hurst D S; Roomans G M; Venge P; Sevéus L
Eosinophils and neutrophils in biopsies from the middle ear of atopic children with otitis media with effusion.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1999;48(12):626-31.
1999: Torsteinsdóttir I; Hâkansson L; Hällgren R; Gudbjörnsson B; Arvidson N G; Venge P
Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(12):1249-54.
1999: Wieslander G; Norbäck D; Wålinder R; Erwall C; Venge P
Inflammation markers in nasal lavage, and nasal symptoms in relation to relocation to a newly painted building: a longitudinal study.
International archives of occupational and environmental health 1999;72(8):507-15.
1999: Liu L; Ridefelt P; Håkansson L; Venge P
Regulation of human eosinophil migration across lung epithelial monolayers by distinct calcium signaling mechanisms in the two cell types.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5649-55.
1999: Dahlén I; Janson C; Björnsson E; Stålenheim G; Peterson C G; Venge P
Inflammatory markers in acute exacerbations of obstructive pulmonary disease: predictive value in relation to smoking history.
Respiratory medicine 1999;93(10):744-51.
1999: Hurst D S; Amin K; Sevéus L; Venge P
Mast cells and tryptase in the middle ear of children with otitis media with effusion.
International journal of pediatric otorhinolaryngology 1999;49 Suppl 1():S315-9.
1999: Wieslander G; Norbäck D; Nordström K; Wålinder R; Venge P
Nasal and ocular symptoms, tear film stability and biomarkers in nasal lavage, in relation to building-dampness and building design in hospitals.
International archives of occupational and environmental health 1999;72(7):451-61.
1999: Venge P; Byström J; Carlson M; Hâkansson L; Karawacjzyk M; Peterson C; Sevéus L; Trulson A
Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1999;29(9):1172-86.
1999: Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
The American journal of gastroenterology 1999;94(7):1876-83.
1999: Fjaertoft G; Håkansson L; Ewald U; Foucard T; Venge P
Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections.
Pediatric research 1999;45(6):871-6.
1999: Lúdvíksdóttir D; Janson C; Högman M; Gudbjörnsson B; Björnsson E; Valtýsdóttir S; Hedenström H; Venge P; Boman G
Increased nitric oxide in expired air in patients with Sjögren's syndrome. BHR study group. Bronchial hyperresponsiveness.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1999;13(4):739-43.
1999: Wålinder R; Norbäck D; Wieslander G; Smedje G; Erwall C; Venge P
Nasal patency and lavage biomarkers in relation to settled dust and cleaning routines in schools.
Scandinavian journal of work, environment & health 1999;25(2):137-43.
1999: Lampinen M; Rak S; Venge P
The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1999;29(3):314-22.
1999: Hurst D S; Amin K; Sevéus L; Venge P
Evidence of mast cell activity in the middle ears of children with otitis media with effusion.
The Laryngoscope 1999;109(3):471-7.
1999: Frostfeldt G; Ahlberg G; Gustafsson G; Helmius G; Lindahl B; Nygren A; Siegbahn A; Swahn E; Venge P; Wallentin L
Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
Journal of the American College of Cardiology 1999;33(3):627-33.
1998: Woschnagg C; Rak S; Venge P
Blood eosinophils from asymptomatic allergics have a reduced capacity to produce oxygen-free radicals.
Allergy 1998;53(12):1162-71.
1998: Lindahl B; Venge P; Wallentin L
The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers.
European heart journal 1998;19 Suppl N():N51-8.
1998: Wålinder R; Norbäck D; Wieslander G; Smedje G; Erwall C; Venge P
Nasal patency and biomarkers in nasal lavage--the significance of air exchange rate and type of ventilation in schools.
International archives of occupational and environmental health 1998;71(7):479-86.
1998: Lilienberg G; Venge P
Platelet adhesion in patients prone to arterial and venous thrombosis: the impact of gender, smoking and heredity.
Scandinavian journal of clinical and laboratory investigation 1998;58(4):279-86.
1998: Håkansson L; Heinrich C; Rak S; Venge P
Activation of B-lymphocytes during pollen season. Effect of immunotherapy.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1998;28(7):791-8.
1998: Venge P; Byström J
Eosinophil cationic protein (ECP).
The international journal of biochemistry & cell biology 1998;30(4):433-7.
1998: Helenius I J; Rytilä P; Metso T; Haahtela T; Venge P; Tikkanen H O
Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers.
Allergy 1998;53(4):346-52.
1997: Borowiec J W; Venge P; Henze A; Nilsson B; Stiernström H
Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits.
The Thoracic and cardiovascular surgeon 1997;45(6):295-301.
1997: Borowiec J; Jaramillo A; Venge P; Nilsson L; Thelin S
Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation.
Cardiovascular surgery (London, England) 1997;5(6):568-73.
1997: Håkansson L; Höglund M; Jönsson U B; Torsteinsdottir I; Xu X; Venge P
Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion.
British journal of haematology 1997;98(3):603-11.
1997: Lindahl B; Andrén B; Ohlsson J; Venge P; Wallentin L
Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group.
The American journal of cardiology 1997;80(5A):40E-44E.
1997: Trulson A; Nilsson S; Venge P
The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer.
British journal of haematology 1997;98(2):312-4.
1997: Borowiec J W; Bozdayi M; Jaramillo A; Nilsson L; Venge P; Henze A
Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin coated cardiopulmonary bypass circuit during coronary revascularization surgery.
Journal of cardiac surgery 1997;12(3):190-7.
1997: Sevéus L; Amin K; Peterson C G; Roomans G M; Venge P
Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells.
Histochemistry and cell biology 1997;107(5):423-32.
1997: Lindahl B; Andrén B; Ohlsson J; Venge P; Wallentin L
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group.
European heart journal 1997;18(5):762-70.
1997: Håkansson L; Heinrich C; Rak S; Venge P
Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy.
The Journal of allergy and clinical immunology 1997;99(4):551-62.
1997: Karawajczyk M; Höglund M; Ericsson J; Venge P
Administration of G-CSF to healthy subjects: the effects on eosinophil counts and mobilization of eosinophil granule proteins.
British journal of haematology 1997;96(2):259-65.
1997: Lindahl B; Venge P; Wallentin L
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group.
Journal of the American College of Cardiology 1997;29(1):43-8.
1996: Laitinen L A; Laitinen A; Altraja A; Virtanen I; Kämpe M; Simonsson B G; Karlsson S E; Håkansson L; Venge P; Sillastu H
Bronchial biopsy findings in intermittent or "early" asthma.
The Journal of allergy and clinical immunology 1996;98(5 Pt 2):S3-6; discussion S33-40.
1996: Altraja A; Laitinen A; Virtanen I; Kämpe M; Simonsson B G; Karlsson S E; Håkansson L; Venge P; Sillastu H; Laitinen L A
Expression of laminins in the airways in various types of asthmatic patients: a morphometric study.
American journal of respiratory cell and molecular biology 1996;15(4):482-8.
1996: Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes T E; Kierulf P
Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
The Annals of thoracic surgery 1996;62(4):1134-40.
1996: Woschnagg C; Rak S; Venge P
Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1996;26(9):1064-72.
1996: Bozdayi M; Borowiec J; Nilsson L; Venge P; Thelin S; Hansson H E
Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery.
Artificial organs 1996;20(9):1008-16.
1996: Xu S; Höglund M; Venge P
The effect of granulocyte colony-stimulating factor (G-CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect.
British journal of haematology 1996;93(3):558-68.
1996: Trulson A; Nilsson S; Venge P
Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication.
Journal of clinical pathology 1996;49(5):381-5.
1996: Lindahl B; Venge P; Wallentin L
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group.
Circulation 1996;93(9):1651-7.
1996: Pedersen B; Dahl R; Karlström R; Peterson C G; Venge P
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
American journal of respiratory and critical care medicine 1996;153(5):1519-29.
1996: Venge J; Lampinen M; Håkansson L; Rak S; Venge P
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung.
The Journal of allergy and clinical immunology 1996;97(5):1110-5.
1996: Hurst D S; Venge P
Levels of eosinophil cationic protein and myeloperoxidase from chronic middle ear effusion in patients with allergy and/or acute infection.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1996;114(4):531-44.
1996: Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes T E; Venge P; Kierulf P
Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
Perfusion 1996;11(2):113-23.
1996: Bjornsson E; Janson C; Hakansson L; Enander I; Venge P; Boman G
Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness.
Respiratory medicine 1996;90(1):39-46.
1996: Venge P; Pedersen B; Håkansson L; Hällgren R; Lindblad G; Dahl R
Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis.
American journal of respiratory and critical care medicine 1996;153(1):312-6.
1995: Moen O; Fosse E; Brockmeier V; Andersson C; Mollnes T E; Høgåsen K; Venge P
Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
The Annals of thoracic surgery 1995;60(5):1317-23.
1995: Karawajczyk M; Pauksen K; Peterson C G; Eklund E; Venge P
The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1995;25(8):713-9.
1995: Schmekel B; Hörnblad Y; Hvatum M; Norlund A L; Venge P
Kinetic retrieval of eosinophil cationic protein, hyaluronan, secretory IgA, albumin, and urea during BAL in healthy subjects.
Chest 1995;108(1):62-7.
1995: Xu S Y; Pauksen K; Venge P
Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections.
Scandinavian journal of clinical and laboratory investigation 1995;55(2):125-31.
1995: Lindahl B; Venge P; Wallentin L
Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes.
Coronary artery disease 1995;6(4):321-8.
1995: Nilsson L; Peterson C; Venge P; Borowiec J W; Thelin S
Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating.
The Annals of thoracic surgery 1995;59(3):713-6.
1995: Borowiec J W; Hagman L; Tötterman T H; Pekna M; Venge P; Thelin S
Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits.
Scandinavian journal of thoracic and cardiovascular surgery 1995;29(4):167-74.
1995: Venge P
Role of eosinophils in childhood asthma inflammation.
Pediatric pulmonology. Supplement 1995;11():34-5.
1994: Björnsson E; Janson C; Håkansson L; Enander I; Venge P; Boman G
Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population.
Allergy 1994;49(9):730-6.
1994: Fosse E; Moen O; Johnson E; Semb G; Brockmeier V; Mollnes T E; Fagerhol M K; Venge P
Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.
The Annals of thoracic surgery 1994;58(2):472-7.
1994: Xu S Y; Carlson M; Engström A; Garcia R; Peterson C G; Venge P
Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils.
Scandinavian journal of clinical and laboratory investigation 1994;54(5):365-76.
1994: Edelstam G; Fredens K; Venge P
Role of eosinophilic granulocytes in women with infertility and pelvic adhesions.
Inflammation 1994;18(4):361-71.
1994: Xu S Y; Petersson C G; Carlson M; Venge P
The development of an assay for human neutrophil lipocalin (HNL)--to be used as a specific marker of neutrophil activity in vivo and vitro.
Journal of immunological methods 1994;171(2):245-52.
1994: Nielsen J; Welinder H; Ottosson H; Bensryd I; Venge P; Skerfving S
Nasal challenge shows pathogenetic relevance of specific IgE serum antibodies for nasal symptoms caused by hexahydrophthalic anhydride.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1994;24(5):440-9.
1994: Venge P
Eosinophil activity in bronchial asthma.
Allergy proceedings : the official journal of regional and state allergy societies 1994;15(3):139-41.
1994: Edelstam G A; Lundkvist O; Venge P; Laurent T C
Hyaluronan and myeloperoxidase in human peritoneal fluid during genital inflammation.
Inflammation 1994;18(2):141-9.
1994: Håkansson L; Venge P
Priming of eosinophil and neutrophil migratory responses by interleukin 3 and interleukin 5.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1994;102(4):308-16.
1994: Höglund M; Simonsson B; Smedmyr B; Oberg G; Venge P
The effect of rGM-CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins.
British journal of haematology 1994;86(4):709-16.
1994: Moen O; Fosse E; Bråten J; Andersson C; Fagerhol M K; Venge P; Høgåsen K; Mollnes T E
Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation.
Perfusion 1994;9(2):109-17.
1994: Trulson A; Nilsson S; Brekkan E; Venge P
Patients with renal cancer have a larger proportion of high-density blood monocytes with increased lucigenin-enhanced chemiluminescence.
Inflammation 1994;18(1):99-105.
1994: Edelstam G A; Lundkvist O; Venge P; Laurent T C
Hyaluronan and myeloperoxidase in human peritoneal fluid during genital inflammation.
Inflammation 1994;18(1):13-21.
1994: Venge P
Soluble markers of allergic inflammation.
Allergy 1994;49(1):1-8.
1994: Carlson M; Oberg G; Peterson C; Venge P
Releasability of human hypereosinophilic eosinophils is related to the density of the cells.
British journal of haematology 1994;86(1):41-7.
1994: Pekna M; Borowiec J; Fagerhol M K; Venge P; Thelin S
Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass.
Scandinavian journal of thoracic and cardiovascular surgery 1994;28(1):5-11.
1993: Carlson M; Peterson C; Venge P
The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Allergy 1993;48(6):437-42.
1993: Hurst D S; Venge P
The presence of eosinophil cationic protein in middle ear effusion.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1993;108(6):711-22.
1993: Venge P
Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1993;23 Suppl 2():3-7, discussion 15-22.
1993: Venge P
The eosinophil granulocyte in allergic inflammation.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 1993;4(4 Suppl):19-24.
1993: Schmekel B; Venge P
Markers for eosinophils and T-lymphocytes as predictors of late asthmatic response.
Allergy 1993;48(17 Suppl):94-7; discussion 110-1.
1993: Venge P
Eosinophil and neutrophil granulocytes.
Allergy 1993;48(17 Suppl):39-47; discussion 48-9.
1992: Borowiec J; Thelin S; Bagge L; Nilsson L; Venge P; Hansson H E
Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
The Journal of thoracic and cardiovascular surgery 1992;104(3):642-7.
1992: Carlson M; Håkansson L; Kämpe M; Stålenheim G; Peterson C; Venge P
Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season.
The Journal of allergy and clinical immunology 1992;89(1 Pt 1):131-9.
1991: Venge P; Henriksen J; Dahl R
Eosinophils in exercise-induced asthma.
The Journal of allergy and clinical immunology 1991;88(5):699-704.
1991: Klementsson H; Svensson C; Andersson M; Venge P; Pipkorn U; Persson C G
Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1991;21(6):705-10.
1991: Gudbjörnsson B; Feltelius N; Hällgren R; Venge P
Neutrophil function in patients with primary Sjögren's syndrome: relation to infection propensity.
Annals of the rheumatic diseases 1991;50(10):685-90.
1991: Bousquet J; Chanez P; Lacoste J Y; Enander I; Venge P; Peterson C; Ahlstedt S; Michel F B; Godard P
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma.
The Journal of allergy and clinical immunology 1991;88(4):649-60.
1991: Peterson C G; Enander I; Nystrand J; Anderson A S; Nilsson L; Venge P
Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1991;21(5):561-7.
1991: Schmekel B; Blom-Bülow B; Hörnblad Y; Laitinen L A; Linden M; Venge P
Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1991;4(7):867-71.
1991: Venge P; Håkansson L
Current understanding of the role of the eosinophil granulocyte in asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1991;21 Suppl 3():31-7.
1991: Videm V; Nilsson L; Venge P; Svennevig J L
Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass.
Artificial organs 1991;15(2):90-5.
1991: Fredens K; Dahl R; Venge P
In vitro studies of the interaction between heparin and eosinophil cationic protein.
Allergy 1991;46(1):27-9.
1991: Carlson M; Håkansson L; Peterson C; Stålenheim G; Venge P
Secretion of granule proteins from eosinophils and neutrophils is increased in asthma.
The Journal of allergy and clinical immunology 1991;87(1 Pt 1):27-33.
1991: Matsson P; Ahlstedt S; Enander I; Peterson C G; Venge P
Measurement of specific markers in the monitoring of the bronchial inflammation in asthma.
Annals of the New York Academy of Sciences 1991;629():383-7.
1991: Klementsson H; Venge P; Andersson M; Pipkorn U
Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes.
Acta oto-laryngologica 1991;111(4):776-84.
1990: Bousquet J; Chanez P; Lacoste J Y; Barnéon G; Ghavanian N; Enander I; Venge P; Ahlstedt S; Simony-Lafontaine J; Godard P
Eosinophilic inflammation in asthma.
The New England journal of medicine 1990;323(15):1033-9.
1990: Klementsson H; Andersson M; Baumgarten C R; Venge P; Pipkorn U
Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1990;20(5):539-47.
1990: Schmekel B; Hörnblad Y; Linden M; Sundström C; Venge P
Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages.
Inflammation 1990;14(4):455-61.
1990: Schmekel B; Karlsson S E; Linden M; Sundström C; Tegner H; Venge P
Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity.
Inflammation 1990;14(4):447-54.
1990: Schmekel B; Wollmer P; Venge P; Linden M; Blom-Bülow B
Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis.
Thorax 1990;45(7):525-9.
1990: Håkansson L; Venge P
Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
Journal of leukocyte biology 1990;47(5):449-56.
1990: Svensson C; Andersson M; Persson C G; Venge P; Alkner U; Pipkorn U
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.
The Journal of allergy and clinical immunology 1990;85(5):828-33.
1990: Håkansson L; Carlson M; Stålenheim G; Venge P
Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma.
The Journal of allergy and clinical immunology 1990;85(4):743-50.
1990: Venge P
What is the role of the eosinophil?
Thorax 1990;45(3):161-3.
1990: Venge P; Henriksen J; Dahl R; Håkansson L
Exercise-induced asthma and the generation of neutrophil chemotactic activity.
The Journal of allergy and clinical immunology 1990;85(2):498-504.
1990: Nilsson L; Tydén H; Johansson O; Nilsson U; Ronquist G; Venge P; Aberg T; Nyström S O
Bubble and membrane oxygenators--comparison of postoperative organ dysfunction with special reference to inflammatory activity.
Scandinavian journal of thoracic and cardiovascular surgery 1990;24(1):59-64.
1990: Nilsson L; Nilsson U; Venge P; Johansson O; Tydén H; Aberg T; Nyström S O
Inflammatory system activation during cardiopulmonary bypass as an indicator of biocompatibility: a randomized comparison of bubble and membrane oxygenators.
Scandinavian journal of thoracic and cardiovascular surgery 1990;24(1):53-8.
1990: Venge P; Brattsand R; Laitinen L A; Persson C G
Which markers of inflammation should be used in therapeutic intervention studies of CB/COAD?
Agents and actions. Supplements 1990;30():289-94.
1990: Venge P; Håkansson L
Indices of inflammatory activity in CB and COAD. Phagocyte secretion and chemotaxis.
Agents and actions. Supplements 1990;30():219-28.
1990: Venge P
A critical look at blood samples in CB and COAD.
Agents and actions. Supplements 1990;30():109-19.
1989: Lavö B; Knutson L; Lööf L; Odlind B; Venge P; Hällgren R
Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease.
The American journal of medicine 1989;87(6):655-60.
1989: Hällgren R; Feltelius N; Garcia R; Venge P; Lindh U
Metal content of neutrophil granules is altered in chronic inflammation.
Inflammation 1989;13(4):383-92.
1989: Andersson M; Andersson P; Venge P; Pipkorn U
Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment.
Allergy 1989;44(5):342-8.
1989: Håkansson L; Rak S; Dahl R; Venge P
The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge.
The Journal of allergy and clinical immunology 1989;83(5):933-9.
1989: Trulson A; Nilsson S; Venge P
Lucigenin-enhanced chemiluminescence in blood is increased in cancer.
American journal of clinical pathology 1989;91(4):441-5.
1989: Hällgren R; Bjermer L; Lundgren R; Venge P
The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.
The American review of respiratory disease 1989;139(2):373-7.
1989: Hällgren R; Colombel J F; Dahl R; Fredens K; Kruse A; Jacobsen N O; Venge P; Rambaud J C
Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.
The American journal of medicine 1989;86(1):56-64.
1989: Venge P; Dahl R
The eosinophil and intrinsic asthma.
Agents and actions. Supplements 1989;28():67-74.
1989: Siegbahn A; Odlind V; Hedner U; Venge P
Coagulation and fibrinolysis during the normal menstrual cycle.
Upsala journal of medical sciences 1989;94(2):137-52.
1988: Venge P; Dahl R; Fredens K; Peterson C G
Epithelial injury by human eosinophils.
The American review of respiratory disease 1988;138(6 Pt 2):S54-7.
1988: Peterson C G; Jörnvall H; Venge P
Purification and characterization of eosinophil cationic protein from normal human eosinophils.
European journal of haematology 1988;40(5):415-23.
1988: Venge P; Dahl R; Peterson C G
Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication.
International archives of allergy and applied immunology 1988;87(3):306-12.
1988: Nilsson L; Brunnkvist S; Nilsson U; Nyström S O; Tydén H; Venge P; Aberg T
Activation of inflammatory systems during cardiopulmonary bypass.
Scandinavian journal of thoracic and cardiovascular surgery 1988;22(1):51-3.
1987: Håkansson L; Westerlund D; Venge P
New method for the measurement of eosinophil migration.
Journal of leukocyte biology 1987;42(6):689-96.
1987: Linder A; Venge P; Deuschl H
Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis.
Allergy 1987;42(8):583-90.
1987: Venge P; Nilsson L; Nyström S O; Aberg T
Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: a model to estimate human turnover of lactoferrin and myeloperoxidase.
European journal of haematology 1987;39(4):339-45.
1987: Siegbahn A; Garcia R C; Kishi K; Nilsson K; Venge P
Specific binding of B-CLL cell-derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes.
European journal of haematology 1987;39(2):172-9.
1987: Peterson C G; Venge P
Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin.
The Biochemical journal 1987;245(3):781-7.
1986: Feltelius N; Lindh U; Venge P; Hällgren R
Ankylosing spondylitis: a chronic inflammatory disease with iron overload in granulocytes and platelets.
Annals of the rheumatic diseases 1986;45(10):827-31.
1985: Schmekel B; Håkansson L; Hällgren R; Nöu E; Stålenheim G; Venge P
C3b receptor-mediated phagocytosis in sarcoidosis with extra-thoracic manifestations.
European journal of respiratory diseases 1985;67(5):341-5.
1985: Schmekel B; Håkansson L; Hällgren R; Nou E; Stålenheim G; Venge P
Neutrophil phagocytosis in sarcoidosis. Reduced C3b receptor-mediated phagocytosis in active and silent sarcoidosis.
Clinical and experimental immunology 1985;60(1):191-5.
1984: Schmekel B; Håkansson L; Hällgren R; Stålenheim G; Venge P
Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis.
European journal of respiratory diseases 1984;65(8):592-9.
1984: Venge P; Foucard T; Henriksen J; Håkansson L; Kreuger A
Serum-levels of lactoferrin, lysozyme and myeloperoxidase in normal, infection-prone and leukemic children.
Clinica chimica acta; international journal of clinical chemistry 1984;136(2-3):121-30.
1982: Hällgren R; Håkansson L; Schmekel B; Stålenheim G; Venge P
Kinetic studies of phagocytosis. IV. Cellular defects and humoral inhibition as causes of impaired neutrophil phagocytosis in sarcoidosis.
Clinical and experimental immunology 1982;47(1):169-75.
1982: Schmekel B; Hällgren R; Stålenheim G; Venge P
Indices of inflammatory cell activity and pulmonary function in different stages of sarcoidosis.
Acta medica Scandinavica 1982;211(5):393-9.

Sign-in to see more